Journal of Functional Biomaterials,
Journal Year:
2024,
Volume and Issue:
15(12), P. 372 - 372
Published: Dec. 9, 2024
CY1-4,
9-nitropyridine
[2',3':4,5]
pyrimido
[1,2-α]
indole
-5,11-
dione,
is
an
indoleamine
2,3-dioxygenase
(IDO)
inhibitor
and
a
poorly
water-soluble
substance.
It
very
important
to
increase
the
solubility
of
CY1-4
improve
its
bioavailability
therapeutic
effect.
In
this
study,
mesoporous
silica
nano-skeleton
carrier
material
Sylysia
was
selected
as
load
then
drug
delivery
system
(MSNM@CY1-4)
prepared
by
coating
hydrophilic
polymer
Hydroxypropyl
methylcellulose
(HPMC)
lipid
Distearoylphosphatidyl-ethanolamine-poly(ethylene
glycol)
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(20)
Published: March 17, 2024
Abstract
Insufficient
tumor
immunogenicity
and
immune
escape
from
tumors
remain
common
problems
in
all
immunotherapies.
Recent
studies
have
shown
that
pyroptosis,
a
form
of
programmed
cell
death
is
accompanied
by
checkpoint
inhibitors,
can
induce
effective
immunogenic
long‐term
activation.
Therapeutic
strategies
to
jointly
pyroptosis
reverse
immunosuppressive
microenvironments
are
promising
for
cancer
immunotherapy.
In
this
regard,
dual‐responsive
supramolecular
polymeric
nanomedicine
(NCSNPs)
self‐cascade
amplify
the
benefits
immunotherapy
designed.
The
NCSNPs
formulated
β‐cyclodextrin
coupling
nitric
oxide
(NO)
donor,
activator,
NLG919,
an
indoleamine
2,3‐dioxygenase
(IDO)
inhibitor,
self‐assembled
through
host–guest
molecular
recognition
hydrophobic
interaction
obtain
nanoparticles.
possess
excellent
accumulation
bioavailability
attributed
ingenious
engineering.
study
not
only
confirms
occurrence
NO‐triggered
first
time
but
also
reverses
microenvironment
sites
via
IDO
inhibitor
enhancing
infiltration
cytotoxic
T
lymphocytes,
achieve
remarkable
inhibition
proliferation.
Thus,
provides
novel
strategy
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(26), P. 16967 - 16981
Published: June 18, 2024
Selective
generation
of
sufficient
pyroptosis
inducers
at
the
tumor
site
without
external
stimulation
holds
immense
significance
for
a
longer
duration
immunotherapy.
Here,
we
report
cascade-amplified
inducer
CSCCPT/SNAP
that
utilizes
reactive
nitrogen
species
(RNS),
self-supplied
from
diffusion-controlled
reaction
between
oxygen
(ROS)
and
nitric
oxide
(NO)
to
potentiate
immunotherapy,
while
both
endogenous
mitochondrial
ROS
stimulated
by
released
camptothecin
NO
initiate
pyroptosis.
Mechanistically,
cascade
amplification
antitumor
immune
response
is
prompted
cooperation
enhanced
RNS
with
long
lifetime,
which
could
be
used
as
trigger
effectively
compensate
inherent
drawbacks
ROS,
resulting
in
long-lasting
favoring
Tumor
growth
efficiently
inhibited
mouse
melanoma
tumors
through
facilitation
oxygen/nitrogen
(RONS)-NO
synergy.
In
summary,
our
therapeutic
approach
supramolecular
engineering
nanotechnology
integrate
producers
donors
tumor-specific
stimulus
responses
into
system
guarantees
synchronous
these
two
elicit
pyroptosis-evoked
response,
using
amplifier.
RONS-NO
synergy
achieves
sustained
robust
cancer
ACS Nano,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 31, 2024
Dendritic
cells
(DCs)
play
a
crucial
role
in
initiating
antitumor
immune
responses.
However,
the
tumor
environment,
dendritic
often
exhibit
impaired
antigen
presentation
and
adopt
an
immunosuppressive
phenotype,
which
hinders
their
function
reduces
ability
to
efficiently
present
antigens.
Here,
dual
catalytic
oxide
nanosponge
(DON)
doubling
as
remotely
boosted
catalyst
inducer
of
programming
DCs
program
therapy
is
reported.
Intravenous
delivery
DON
enhances
accumulation
via
marginated
target.
At
site,
incorporates
cerium
nanozyme
(CeO
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 30, 2025
Abstract
The
massive
amount
of
indoleamine
2,3‐dioxygenase
1
(IDO‐1)
in
tumor
cells
and
tumor‐associated
immune
forms
a
feedback
loop
that
maintains
immunosuppressive
microenvironment
(ITM)
causes
escape,
resulting
the
poor
prognosis
platinum
chemotherapeutics.
However,
effective
systemic
administration
drugs
IDO‐1
inhibitors
is
strictly
limited
by
their
distinct
chemical
construction,
different
pharmacokinetic
profiles,
heterogeneous
distributions.
Herein,
novel
supramolecular
method
with
capability
to
modulate
proposed
aiming
at
potentiating
antitumor
efficacy
chemoimmunotherapy.
Profiting
from
dynamic
reversible
merits
noncovalent
interactions,
inhibitor
(IDOi)
1,2‐diaminocyclohexane‐platinum(II)
(DACHPt)
are
tailor‐encapsulated
into
nanoparticles
(SNPs)
aid
host−guest
recognition
metal
coordination,
respectively,
effectively
increasing
drug
loading
improving
pharmacokinetics.
In
addition
authorized
chemotherapeutical
effect,
DACHPt
performs
response,
which
further
magnified
IDOi‐reversed
ITM
encourage
T
lymphocyte
infiltration,
guaranteeing
long‐term
responses
improve
cancer
prognosis.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 24, 2025
Abstract
Poor
prognosis
and
chemotherapy
response
stem
from
difficulties
in
precise
targeting
the
lack
of
effective
synergistic
treatments.
Nanozymes
show
promising
potential
tumor
chemodynamic
therapy
(CDT)
by
catalyzing
hydrogen
peroxide
(H₂O₂)
decomposition
glutathione
depletion
microenvironment
(TME).
However,
integrating
with
CDT
remains
challenging.
In
this
study,
a
porous
Fe/Cu
bimetallic
nanozyme
carrier
(FeCuNPs)
is
developed
for
co‐loading
humanized
3F8
anti‐GD2
disialoganglioside
antibody
(3F8)
novel
pyridazinone‐based
chemotherapeutic
agent
(IMB),
forming
nanoreactor
(3F8@FeCuNPs@IMB)
targeted
CDT.
The
responds
specifically
to
acidic
TME
as
primary
insurance,
allowing
controlled
release
IMB
at
site.
coating
on
surface
acts
secondary
minimizing
drug
leakage
during
delivery
process
ensuring
chemotherapy.
Furthermore,
FeCuNPs
act
peroxidase‐like
(POD)
oxidase‐like
(GSHOX)
enzymes,
hydroxyl
radical
(•OH)
generation
depleting
excess
GSH,
enhancing
results
vitro
vivo
indicate
that
dual
insurance
designed
3F8@FeCuNPs@IMB
offers
prospect
targeted,
precise,
combination
against
melanoma.
Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 15, 2025
Abstract
There
is
a
desperate
need
for
precise
nanomedications
to
treat
ischemic
cerebral
injury.
Yet,
the
drawbacks
of
poor
delivery
efficiency
and
off‐target
toxicity
in
pathologic
parenchyma
traditional
antioxidants
against
stroke
result
inadequate
brain
accumulation.
M13
bacteriophages
are
highly
phagocytosed
by
M1‐polarized
microglia
can
be
carried
toward
neuroinflammatory
sites.
Here,
bio‐active,
inhalable,
Ce
0.9
Zr
0.1
O
2
‐backpacked‐M13
phage
(abbreviated
as
CZM)
developed
demonstrates
how
taken
up
different
phenotypes’
microglia.
With
M1
microglia's
proliferating
migrating,
CZM
extensively
specifically
delivered
site
core
penumbra,
where
surviving
nerve
cells
shielded
from
secondary
oxidative
stress
inflammatory
cascade
initiated
reactive
oxygen
species
(ROS).
non‐invasive
administration,
effectively
alleviates
damage
apoptosis
neurons
eliminating
ROS
generated
hyperactive
secure
effective
strategy
targeted
therapy
maladies
offered
this
research.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 15, 2025
Abstract
Pyroptosis,
a
programmed
necrotic
cell
death
mediated
by
gasdermin,
can
activate
strong
immune
responses
and
serve
as
potential
target
for
cancer
therapy.
Nevertheless,
the
relatively
large
molecular
size
negative
surface
charge
of
gasdermin
impede
them
from
effectively
intracellular
delivery
directly
inducing
pyroptosis.
Here,
cytosolic
protein
system,
fluorinated
iron
oxide
nanoparticles
(FIONPs)
is
reported,
which
self‐assemble
with
active
A3
(GSDMA3)
via
noncovalent
interactions
trigger
pyroptosis
in
4T1
cells.
It
proved
that
system
versatile
various
cargo
proteins
(ribonuclease
A,
saporin,
β‐galactosidase,
bovine
serum
albumin)
different
isoelectric
points
weights,
without
compromising
their
biological
activity
vitro.
What's
more,
under
magnetic
drive,
FIONPs
facilitate
transport
GSDMA3
vivo,
further
augmenting
tumor
suppression
response.
Overall,
magnetic‐driven
provide
an
effective
transductions,
application
reveals
direct
significantly
elicits
robust
antitumor
immunity
induction
Small,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 21, 2025
Abstract
Low‐temperature
second
near‐infrared
region
(NIR‐II)
photothermal
therapy
(PTT)
has
shown
significant
potential
in
minimizing
damage
to
normal
tissues
and
reducing
inflammation.
However,
it
still
faces
challenge
of
insufficient
immune
response.
Thus,
a
multifunctional
phototheranostic
nanoparticle
(BDPB/Pt/Fe@P[5])
is
developed
by
co‐loading
BDPB,
CDHPt,
Fe
2
⁺
with
pH‐sensitive
lipid
DSPE‐PEOz2K.
The
carboxylatopillar[5]arene
(CP[5])
used
construct
this
exhibits
strong
host–guest
recognition
pyridine
salts,
alleviating
aggregation
caused
quench
(ACQ)
effect
enhancing
the
NIR‐II
emission
donor–acceptor–donor
(D–A–D)‐type
organic
small
molecule
(BDPB).
CP[5]
provides
suitable
vehicles
for
encapsulating
platinum
(IV)
prodrugs
(CDHPt)
ions
via
metal
coordination
controllable
reactive
oxygen
species
(ROS)
release.
Under
low‐intensity
laser
irradiation
an
acidic
tumor
microenvironment,
nanoparticles
degrade,
releasing
CDHPt
platinum‐based
chemodynamic
(CDT).
facilitates
direct
production
superoxide
anions
(O₂·⁻)
from
O₂
partially
converts
into
highly
cytotoxic
hydroxyl
radicals,
thereby
promoting
Fenton
reaction
process.
therapeutic
efficacy
further
synergized
immunogenic
cell
death
(ICD)
effect.
Frontiers in Chemistry,
Journal Year:
2024,
Volume and Issue:
12
Published: Oct. 10, 2024
Cancer
immunotherapy
has
emerged
as
a
pivotal
approach
for
treating
various
types
of
cancer,
incorporating
strategies
such
chimeric
antigen
receptor
T-cell
(CAR-T)
therapy,
immune
checkpoint
blockade
neoantigen
peptides,
mRNA
vaccines,
and
small
molecule
modulators.
However,
the
clinical
efficacy
these
therapies
is
frequently
constrained
by
significant
adverse
effects
limited
therapeutic
outcomes.
In
recent
years,
integration
nanotechnology
into
cancer
gained
considerable
attention,
showcasing
notable
advantages
in
drug
delivery,
targeted
accumulation,
controlled
release,
localized
administration.
This
review
focuses
on
nanomaterial-based
immunotherapeutic
strategies,
particularly
development
application
nanocarriers
liposomes,
lipid
nanoparticles,
polymeric
self-assembling
scaffolds.
We
examine
how
can
enhance
while
minimizing
analyze
their
potential
translation.